Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-05-31
2011-05-31
Rao, Deepak (Department: 1624)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
C514S259410, C544S282000
Reexamination Certificate
active
07951809
ABSTRACT:
The present invention relates to inhibitors of p38, a mammalian protein kinase involved cell proliferation, cell death and response to extracellular stimuli. The invention also relates to methods for producing these inhibitors. The invention also provides pharmaceutical compositions comprising the inhibitors of the invention and methods of utilizing those compositions in the treatment and prevention of various disorders.
REFERENCES:
patent: 5716955 (1998-02-01), Adams et al.
patent: 5716972 (1998-02-01), Adams et al.
patent: 5717100 (1998-02-01), Selnick et al.
patent: 5753664 (1998-05-01), Aono et al.
patent: 5945418 (1999-08-01), Bemis et al.
patent: 6093742 (2000-07-01), Salituro et al.
patent: 6147080 (2000-11-01), Bemis et al.
patent: 6608060 (2003-08-01), Bemis et al.
patent: 6632945 (2003-10-01), Salituro et al.
patent: 7115637 (2006-10-01), Salituro et al.
patent: 7205305 (2007-04-01), Bemis et al.
patent: 7365072 (2008-04-01), Bemis et al.
patent: 7423049 (2008-09-01), Salituro et al.
patent: 2009/0075981 (2009-03-01), Salituro et al.
patent: WO 95/02591 (1995-01-01), None
patent: WO 95/31451 (1995-11-01), None
patent: WO 96/21654 (1996-07-01), None
patent: WO 97/12876 (1997-04-01), None
patent: WO 97/19065 (1997-05-01), None
patent: WO 97/44467 (1997-11-01), None
patent: WO 97/47618 (1997-12-01), None
patent: WO 97/49689 (1997-12-01), None
patent: WO 98/02430 (1998-01-01), None
patent: WO 98/06715 (1998-02-01), None
Gallagher et al., “Regulation of Stress Induced Cytokine Production by Pyridinylimidazoles; Inhibition of CSBP Kinase,” Bioorganic & Medicinal Chemistry, 5(1), pp. 49 64, (1997).
Badger et al., “Pharmacological Profile of SB 203580, a Selective Inhibitor of Cytokine Suppressive Binding Protein/p38 Kinase, in Animal Models of Arthritis, Bone Resorption, Endotoxin Shock and Immune Function,” Journal of Pharmacology and Experimental Therapeutics, 279(3), pp. 1453-1461, (1996).
Gallagher et al., “2,4,5 Triaryl imidazole Inhibitors of IL 1 Biosynthesis,” Bioorganic & Medicinal Chemistry Letters, 5 (11), pp. 1171-1176, (1995).
Layzer, “Degenerative Diseases of the Nervous System,” Cecil Textbook of Medicine, 20th Edition, vol. 1 pp. 2050-2057 (1996).
Simone, “Oncology: Introduction,” Cecil Textbook of Medicine, 20th Edition, vol. 1 pp. 1004-1010 (1996).
Damasio, “Alzheimer's Disease and Related Dementias,” Cecil Textbook of Medicine, 20th Edition, vol. 1 pp. 1992-1996 (1996).
Douglas, “Introduction to Viral Diseases,” Cecil Textbook of Medicine, 20th Edition, vol. 1 pp. 1739-1747 (1996).
Mass, R. D., Int. J. Radiation Oncology Bio. Phys.vol. 58(3): 932-940, 2004.
Fabbro et al. Pharmacology & therapeutics 93, 79-98, 2002.
Cohen et al., Current Opinion in Chemical Biology, 3,459-465, 1999.
Freshney et al.,Culture of Animal Cells, A Manual of Basic Technique, Alan R. Liss, Inc., 1983, New York, p. 4.
Dermer et al., Bio/Technology, 1994, 12:320.
Powell et al., British Journal of Dermatology, 141 802-810,1999.
Golub et al., Science, 286, 531-537,1999.
Turner et al., Current Pharmaceutical Design. 2, 209-224, 1996.
Sugar et al., Diagn. Microbial. Infect. Dis. 21: 129-133, 1995.
Snyder et al., J. Med. Liban 48(4): 208-214, 2000 (Abstract).
Brunet et al., Essays Biochem. 32: 1-16,1997 (Abstract).
Nagarkatti et al., J. Mol. Cell Cardiol. 30(8): 1651-1664, 1998 (Abstract).
Herlaar et al., Mol. Med. Today 5(10) 439-447, 1999 (Abstract).
Graninger et al., Curr. Opin. Rheumatol. 13(3):209-13, 2001 (Abstract).
Suzuki et al., FEBS Lett. 465:23-27, 2000.
Badger et al., Arthritis Rheum. 43: 175-183, 2000.
Hommes et al., Gastroenterology 122:7-14, 2002.
Ballard-Croft, C. et al., Am. J. Physiol. Heart Circ. Physiol. 280:H1970-H1981, 2001.
Shimamoto et al., American Heart Association Annual Meeting, 1415 (2000).
Nick et al., J. Immunol. 164:2151-2159,2000.
Legos et al., Brain Research 892:70-77, 2001.
Barancik et al., J. Cardiovasc. Pharmacol. 35:474-483,2000.
Bemis Guy W.
Cochran John E.
Duffy John P.
Galullo Vincent P.
Harrington Edmund M.
Rao Deepak
Roise David A.
Vertex Pharmaceuticals Incorporated
Virtual Law Partners LLP
LandOfFree
Inhibitors of p38 does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibitors of p38, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibitors of p38 will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2700419